Trinity Capital Inc. reports developments as an alternative asset manager and specialty lender focused on private credit for growth-oriented companies. Its recurring news includes quarterly financial results, net investment income, NAV movement, new commitments, funded investments, repayments, exits, and portfolio activity across Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences.
Company updates also cover secured loans, equipment financings, warrant and equity investments, sponsored investment funds, SBIC-related activity, and growth-capital facilities for portfolio companies in technology, life sciences, medical technology, energy infrastructure, and other innovation-driven markets.
Trinity Capital (NYSE: TRIN) has priced an underwritten public offering of $350.0 million in notes due 2032. The unsecured notes bear 7.50% annual interest, payable semiannually beginning January 15, 2027, and mature on January 15, 2032.
The company expects the offering to close on October 5, 2026, subject to customary closing conditions. Trinity intends to use net proceeds to pay down part of its outstanding KeyBank Credit Facility debt and for general corporate purposes. It may redeem the notes in whole or in part at any time at par, plus a make-whole premium, if applicable—a potential additional redemption payment.
Trinity Capital (TRIN) entered into a $50 million corporate debt facility with Wayflyer, a Dublin-based working capital provider for small businesses. The facility expands the pool of growth capital available to Wayflyer and supports rising demand for its funding products and investments in areas such as its AI capability, Intelligence.
For Trinity, the transaction extends its European lending programme run from its London office. Wayflyer has recently added a $1.5 billion forward flow arrangement with Fortress Investment Group and a $250 million credit facility with ATLAS SP Partners, bringing its total funding capacity to deploy up to $4.5 billion over 24 months. Trinity has deployed more than $6.2 billion across over 490 investments as of June 30, 2026.
Trinity Capital (TRIN) declared monthly cash dividends of $0.17 per share for October, November and December 2026.
The fourth-quarter 2026 distributions match the monthly rate paid during the first nine months of 2026, and shareholders have now received a consistent or increased dividend for seven consecutive years. For these dividends, the record dates are October 15, November 13, and December 11, 2026, with payment dates on October 30, November 30, and December 31, 2026, respectively.
The company targets regular dividends equal to about 90%–100% of taxable quarterly or annual income to maintain regulated investment company tax status and may also pay supplemental dividends or spill over excess taxable income into the following year.
Trinity Capital (NYSE: TRIN) announced an equipment financing commitment to LuxWall, a developer of Transparent Insulation based on vacuum insulation technology. According to Trinity Capital, the financing will support LuxWall’s manufacturing expansion to increase production capacity and scale deployment of its energy-efficient window solutions across global residential and commercial buildings.
Trinity Capital (NYSE: TRIN) has appointed Matt Nuyen as Director of Originations on its Equipment Finance team, based in Phoenix, Arizona. With roughly two decades of experience in commercial equipment finance and structured debt, he is expected to enhance opportunity sourcing, partnerships, and customized capital solutions for high-growth companies.
Trinity Capital (NYSE: TRIN) reported Q2 2026 total investment income of $87.2 million, up 25.5% year-over-year, and net investment income (NII) of $46.0 million, or $0.51 per basic share, up 32.1% year-over-year. Return on average equity was 15.2% and return on average assets was 6.9%. Net increase in net assets from operations was $44.4 million, or $0.49 per share.
Total net assets rose 8.6% year-to-date to $1.3 billion, with NAV per share increasing to $13.47. The investment portfolio reached about $2.7 billion at fair value, with debt investments 89.3% first-lien and 81.5% floating-rate. Q2 originations totaled $709.0 million in new commitments and $618.7 million of gross fundings, while exits and repayments were $378.3 million. Non-accrual investments were $18.7 million, or 0.8% of the debt portfolio at fair value. Trinity declared $0.17 monthly dividends for July–September 2026 (totaling $0.51) and raised $99.5 million of net equity ATM proceeds in Q2, plus $11.6 million subsequently. On July 27, 2026, TRIN, TRNI and TRNZ transferred their listings to the NYSE and NYSE Texas.
Trinity Capital (NYSE: TRIN) began trading today on the New York Stock Exchange and NYSE Texas following a strategic transfer from its prior listing venue. The company describes the move as aimed at enhancing its profile among institutional investors and financial-sector peers. Trinity Capital’s common stock continues under ticker TRIN.
The company’s two Fixed Rate Senior Notes due 2029, formerly listed on Nasdaq as TRINZ and TRINI, have also transferred to the NYSE and NYSE Texas and now trade under new symbols TRNZ and TRNI, respectively.
Trinity Capital (Nasdaq: TRIN) plans to transfer the listing of its common stock from Nasdaq to the New York Stock Exchange and NYSE Texas, with NYSE trading expected to begin on or about July 27, 2026, while retaining the ticker symbol TRIN.
The company’s two 7.875% Fixed Rate Senior Notes due March 2029 and September 2029, currently trading on Nasdaq as TRINZ and TRINI, are also expected to move to the NYSE and NYSE Texas on or about July 27, 2026 under new symbols TRNZ and TRNI.
Trinity Capital (Nasdaq: TRIN) reported strong portfolio activity for Q2 and the first half of 2026. Q2 new commitments reached $709 million, with $619 million of gross investments funded and $378 million of repayments and exits.
First-half 2026 totals included $925 million in gross investments funded, $1.1 billion in new commitments and $616 million in repayments and exits. Trinity plans to release full Q2 2026 financial results and hold a conference call on August 5, 2026.
Pearl Health announced a $110 million capital raise, including a $50 million equity round led by Andreessen Horowitz and a $60 million credit facility from Trinity Capital. The funds will expand its AI platform, support Medicare Advantage entry, and grow enterprise health system and payer partnerships.
The company reached profitability in 2025, manages about $3.6 billion in annualized medical spend for 250,000+ Medicare beneficiaries, and projects $500 million in gross healthcare savings while tripling its patient base from 2024 through 2026.